Hologic Symposium: High Volume Screening

Hologic
Several locations have started high volume screening with Hologic 3D Mammography™ in Europe. A large scale adoption is ongoing in the USA with some locations past their third screening round with Hologic 3D Mammography. Results from the use of this technology in screening are concordant and very positive around an increase in invasive cancer detection and a reduction in recall rates.
Practical advices regarding Hologic 3D Mammography™ implementation are discussed in many forums and so are the impact on screening assessment. Leaders using Hologic 3D Mammography™ in screening will share their experiences from implementation and give their view on further positive evolutions in the future.
Friday, March 4th 14.00 - 15.00 Austria Center - Hall C
Moderator of Session:
Prof. emer Per Skaane

Source & Image Credit : Hologic

Published on : Mon, 15 Feb 2016



Related Articles
Hologic

Hologic Inc. (Nasdaq: HOLX) has announced that a new longitudinal study published online in advance of print in JAMA Oncology reports... Read more

The CE-Marked Affirm™ Prone Biopsy System Provides Enhanced 2D/3D™ Biopsy Imaging and Faster, Easier Access to the Breast [i]Hologic,... Read more

Hologic, Inc. (Nasdaq: HOLX) has announced that the Company plans to release its financial results for the second quarter of fiscal... Read more

Hologic,Symposium,Screening, Mammography Several locations have started high volume screening with Hologic 3D Mammography™ in Europe. A large scale adoption is ongoing in the USA with some locations past their third screening round with Hologic 3D Mammography. Results from the use of this techno

No comment


Please login to leave a comment...

Highlighted Products